Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Law

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancerDoreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
JTCVS Open|May 4, 2026
Preoperative circulating tumor DNA detection and occult lymph node metastases in clinical stage I lung cancer: The lung DETECT studyZachary Coyne, Jamie Feng, Sameena Khan, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
JAMA Network Open|July 25, 2023
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical TrialMiguel García-Pardo, Kasia Czarnecka-Kujawa, Jennifer H Law, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2026
Identifying patients with high risk stage I NSCLC using tumor-informed plasma ctDNAJamie Feng, Sameena Khan, Thomas Waddell, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancerDoreen A Ezeife, Eldon Spackman, Rosalyn A Juergens, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
JTCVS Open|May 4, 2026
Preoperative circulating tumor DNA detection and occult lymph node metastases in clinical stage I lung cancer: The lung DETECT studyZachary Coyne, Jamie Feng, Sameena Khan, et al.
Cancer Treatment and Research Communications|March 12, 2022
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare systemKirstin Perdrizet, Tracy L Stockley, Jennifer H Law, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
JAMA Network Open|July 25, 2023
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical TrialMiguel García-Pardo, Kasia Czarnecka-Kujawa, Jennifer H Law, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2026
Identifying patients with high risk stage I NSCLC using tumor-informed plasma ctDNAJamie Feng, Sameena Khan, Thomas Waddell, et al.
Pageof 3